Omicron may be significantly better at evading vaccine-induced immunity, but less likely to cause severe disease

6 comments
  1. Can’t wait for one of the lockdown brigade to swoop in here and try to dampen this despite multiple nation’s now saying it is less deadly to even unvaccinated people and that the vaccinated are incredibly well protected from illness.

    Belief is this variant has been around and growing since October

  2. This is the second study (that I’m aware of) coming to a similar conclusion from lab studies. We’ll find out how true it is in the real world (in the UK) later this week. If it turns out to be correct then it’s superb, it would mean that Omicron will overtake Delta as the dominant variant (because it’s more transmissible) and result in much less bad health outcomes, and we could potentially get back to normal (not 2021 normal, but real 2019 style normal) quite quickly.

  3. Can I get opinion on what’s going on here.

    I got double jabbed, worked from home, didn’t travel, haven’t had a holiday overseas and didn’t see my family. I basically done everything asked of me as I felt it was the right thing to do, but I’m now turning into a massive sceptic…and I doubt I’m alone.
    I’ve never been in the foil hat brigade but I can now feel myself going that way . Wtf🤷

  4. It’s basically got the vaccine to behave as hoped. The suppression of infection rate was always a bonus.

  5. >Of particular concern, antibodies from the majority of individuals whohad received two doses of the AstraZeneca vaccine were unable toneutralise the virus. The data were confirmed in live virus experiments. Reassuringly, however, following a third dose of the Pfizer vaccine, both groups saw a significant increase in neutralisation.

    So one of the best departments in the world is now releasing non-peer reviewed studies, that support big pharma corporations business models.

    I guarantee nobody will ever study whether a group that received their first dose in November and a group that received a third at the same time, had similar levels of immunity. The best thing about these vaccines is they have very limited immunity in time and the entire media will go into a frenzy over mild variants.

    The study is basically saying the first 2 doses received earlier in the year were pointless unless they can prove the first 2 doses were key to the third dose being so effective.

Leave a Reply